CAS Number: 214766-78-6
EC Number: 807-277-4
Molecular Weight: 1632.3
Chemical Formula: C₈₂H₁₀₃ClN₁₈O₁₆
IUPAC Name: (4S)-N-[4-[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2R)-2-[[(2R)-2-acetamido-3-naphthalen-2-ylpropanoyl]amino]-3-(4-chlorophenyl)propanoyl]amino]-3-pyridin-3-ylpropanoyl]amino]-3-hydroxypropanoyl]amino]-3-[[(2R)-1-[[(2S)-1-[[(2S)-1-[(2S)-2-[[(2R)-1-amino-1-oxopropan-2
함량(Assay): 약전(USP/EP/BP) 또는 자체 함량 규격 충족, 일반적으로 HPLC/적정법 기준 98.0% 이상
Purity: 약전/자체 순도 규격 충족, 관련 물질이 관리되는 의약품/원료의약품(API) 등급
불순물 프로파일: ICH Q3A/Q3B 가이드라인의 개별 및 총 유연물질 한도를 충족

기타 정보

추가 설명:

Degarelix Acetate (CAS No. 214766-78-6) has the sequence Ac-D2Nal-D4Cpa-3Pal-Ser-4Aph(Hor)-D4Aph(Cbm)-Leu-Lys(Ipr)-Pro-DAla-NH2, molecular formula C82H103ClN18O16 and molar mass 1630.75 g/mol, with purity of at least 98% and impurities under 0.5%. It is stored at 2-8C and supplied in 1g, 10g or 50g bottles, or to customer requirements. Degarelix is used to treat prostate cancer, specifically advanced hormone-dependent prostate carcinoma.